(Q41628975)

5 October 2017

1 reference

title

Poxviruses as expression vectors (English)

1 reference

5 October 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9353230

22 November 2024

B. Moss

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9353230

22 November 2024

M. W. Carroll

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9353230

22 November 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9353230

22 November 2024

publication date

1 October 1997

1 reference

5 October 2017

October 1997

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9353230

full work available at URL

22 November 2024

https://api.elsevier.com/content/article/PII:S0958166997800316?httpAccept=text/xml

1 reference

DOI

https://api.crossref.org/works/10.1016/S0958-1669(97)80031-6

https://api.elsevier.com/content/article/PII:S0958166997800316?httpAccept=text/plain

22 November 2024

1 reference

DOI

https://api.crossref.org/works/10.1016/S0958-1669(97)80031-6

Current Opinion in Biotechnology

22 November 2024

published in

1 reference

5 October 2017

1 reference

5 October 2017

1 reference

5 October 2017

page(s)

573-577

1 reference

Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety

5 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980031-6

7 January 2021

Applications of pox virus vectors to vaccination: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980031-6

7 January 2021

Vaccinia virus: a selectable eukaryotic cloning and expression vector

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980031-6

7 January 2021

Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980031-6

7 January 2021

A vaccinia virus transfer vector using a GUS reporter gene inserted into the I4L locus

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980031-6

7 January 2021

Infection of frog neurons with vaccinia virus permits in vivo expression of foreign proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980031-6

7 January 2021

Selection of recombinant vaccinia viruses on the basis of plaque formation

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980031-6

7 January 2021

Reverse guanine phosphoribosyltransferase selection of recombinant vaccinia viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980031-6

7 January 2021

Construction of fowlpox virus vectors with intergenic insertions: expression of the beta-galactosidase gene and the measles virus fusion gene.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980031-6

7 January 2021

A novel vaccinia virus expression system allowing construction of recombinants without the need for selection markers, plasmids and bacterial hosts

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980031-6

7 January 2021

Construction and Characterization of Vaccinia Direct Ligation Vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980031-6

7 January 2021

Development of a replication-deficient recombinant vaccinia virus vaccine effective against parainfluenza virus 3 infection in an animal model

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980031-6

7 January 2021

Compact, Synthetic, Vaccinia Virus Early/Late Promoter for Protein Expression

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980031-6

7 January 2021

Construction of a vaccinia virus deficient in the essential DNA repair enzyme uracil DNA glycosylase by a complementing cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980031-6

7 January 2021

Stringent chemical and thermal regulation of recombinant gene expression by vaccinia virus vectors in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980031-6

7 January 2021

Recombinant protein synthesis in Chinese hamster ovary cells using a vaccinia virus/bacteriophage T7 hybrid expression system

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980031-6

7 January 2021

Replication-deficient vaccinia virus encoding bacteriophage T7 RNA polymerase for transient gene expression in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980031-6

7 January 2021

Non-replicating vaccinia vector efficiently expresses bacteriophage T7 RNA polymerase

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980031-6

7 January 2021

Raccoon poxvirus feline panleukopenia virus VP2 recombinant protects cats against FPV challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980031-6

7 January 2021

Fine mechanisms of ectromelia virus thymidine kinase-negative mutants avirulence

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980031-6

7 January 2021

Recombinant capripoxvirus expressing the hemagglutinin protein gene of rinderpest virus: protection of cattle against rinderpest and lumpy skin disease viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980031-6

7 January 2021

Construction of recombinant myxoma viruses expressing foreign genes from different intergenic sites without associated attenuation.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980031-6

7 January 2021

Fowlpox virus host range restriction: gene expression, DNA replication, and morphogenesis in nonpermissive mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980031-6

7 January 2021

Expression of bacteriophage T7 RNA polymerase in avian and mammalian cells by a recombinant fowlpox virus

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980031-6

7 January 2021

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980031-6

7 January 2021

An infectious clone of human parainfluenza virus type 3

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980031-6

7 January 2021

Rescue of a segmented negative-strand RNA virus entirely from cloned complementary DNAs

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980031-6

7 January 2021

Vaccinia virus transfection of hippocampal slice neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980031-6

7 January 2021

Elimination of fox rabies from Belgium using a recombinant vaccinia-rabies vaccine: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980031-6

7 January 2021

Multiple immunizations with attenuated poxvirus HIV type 2 recombinants and subunit boosts required for protection of rhesus macaques.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980031-6

7 January 2021

Human safety and immunogenicity of a canarypox-rabies glycoprotein recombinant vaccine: an alternative poxvirus vector system

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980031-6

7 January 2021

Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980031-6

7 January 2021

p53 as a target for cancer vaccines: recombinant canarypox virus vectors expressing p53 protect mice against lethal tumor cell challenge.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980031-6

7 January 2021

Highly attenuated modified vaccinia virus Ankara (MVA) as an effective recombinant vector: a murine tumor model

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980031-6

7 January 2021

A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980031-6

7 January 2021

Results of a phase I trial of a recombinant vaccinia virus that expresses carcinoembryonic antigen in patients with advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980031-6

7 January 2021

First EBV vaccine trial in humans using recombinant vaccinia virus expressing the major membrane antigen

1 reference

https://api.crossref.org/works/10.1016/S0958-1669(97)80031-6

22 November 2024

Identifiers

DOI

1 reference

5 October 2017

1 reference